Impaired CD4 <sup>+</sup> T cell response to apolipoprotein B-100 peptide P210 in atherosclerotic cardiovascular disease is reversed by P210-conjugated nanoparticles

Paul C. Dimayuga, Jianchang Zhou, Xiaoning Zhao, Janet Wei, Noah Trac, Karla Lambaren, Eun Ji Chung, Bojan Cercek, Prediman K. Shah, Kuang-Yuh Chyu

Open source

DOI: 10.1152/ajpheart.00406.2026
Published: 2026-10-01
Container: American Journal of Physiology-Heart and Circulatory Physiology
Publisher: American Physiological Society
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1152/ajpheart.00406.2026,
  title = {Impaired CD4
                    <sup>+</sup>
                    T cell response to apolipoprotein B-100 peptide P210 in atherosclerotic cardiovascular disease is reversed by P210-conjugated nanoparticles},
  author = {Paul C. Dimayuga and Jianchang Zhou and Xiaoning Zhao and Janet Wei and Noah Trac and Karla Lambaren and Eun Ji Chung and Bojan Cercek and Prediman K. Shah and Kuang-Yuh Chyu},
  year = {2026},
  journal = {American Journal of Physiology-Heart and Circulatory Physiology},
  doi = {10.1152/ajpheart.00406.2026},
  url = {https://doi.org/10.1152/ajpheart.00406.2026}
}

RIS

TY  - JOUR
TI  - Impaired CD4
                    <sup>+</sup>
                    T cell response to apolipoprotein B-100 peptide P210 in atherosclerotic cardiovascular disease is reversed by P210-conjugated nanoparticles
AU  - Paul C. Dimayuga
AU  - Jianchang Zhou
AU  - Xiaoning Zhao
AU  - Janet Wei
AU  - Noah Trac
AU  - Karla Lambaren
AU  - Eun Ji Chung
AU  - Bojan Cercek
AU  - Prediman K. Shah
AU  - Kuang-Yuh Chyu
PY  - 2026
JO  - American Journal of Physiology-Heart and Circulatory Physiology
DO  - 10.1152/ajpheart.00406.2026
UR  - https://doi.org/10.1152/ajpheart.00406.2026
ER  -

APA

Dimayuga, P. C., Zhou, J., Zhao, X., Wei, J., Trac, N., Lambaren, K., Chung, E. J., Cercek, B., Shah, P. K., & Chyu, K. (2026). Impaired CD4 <sup>+</sup> T cell response to apolipoprotein B-100 peptide P210 in atherosclerotic cardiovascular disease is reversed by P210-conjugated nanoparticles. American Journal of Physiology-Heart and Circulatory Physiology. https://doi.org/10.1152/ajpheart.00406.2026

Source records

crossref · retrieved 2026-09-25T14:20:32.059Z